John Vavricka Atea Pharmaceuticals, Inc. (AVIR) insider trading activity

AVIR Quotes by TradingView

John Vavricka is Chief Commercial Officer of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 52,081 shares of AVIR, which is worth approximately $161,971. The most recent transaction as insider was on Jan 31, 2025, when has been sold 11,517 shares (Common Stock) at a price of $3.06 per share, resulting in proceeds of $35,242. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.1K
142.07% 3M change
142.07% 12M change
Total Value Held $161,971

John Vavricka Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2025
SELL
Payment of exercise price or tax liability
$35,242 $3.06 p/Share
11,517 Reduced 18.11%
52,081 Common Stock
Jan 31 2025
BUY
Grant, award, or other acquisition
-
8,750 Added 12.09%
63,598 Common Stock
Jan 31 2025
BUY
Exercise of conversion of derivative security
-
33,333 Added 37.8%
54,848 Common Stock
Feb 01 2024
SELL
Open market or private sale
$45,384 $3.84 p/Share
11,819 Reduced 35.46%
21,515 Common Stock
Jan 31 2024
BUY
Exercise of conversion of derivative security
-
33,334 Added 50.0%
33,334 Common Stock
JV

John Vavricka

Chief Commercial Officer
Boston, MA

Track Institutional and Insider Activities on AVIR

Follow Atea Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVIR shares.

Notify only if

Insider Trading

Get notified when an Atea Pharmaceuticals, Inc. insider buys or sells AVIR shares.

Notify only if

News

Receive news related to Atea Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVIR